Hefei Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Affiliated Hospital of Hebei University · ORCID：0000-0003-1081-6604

发表论文 34 篇 · 总被引 376 次 · h-index 12

代表论文

• Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways (2021 · Frontiers in Cell and Developmental Biology · 被引 38)
• The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis (2017 · Bioscience Reports · 被引 38)
• LncRNA LOXL1‐AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR‐423‐5p and targeting MYBL2 (2019 · Cancer Medicine · 被引 32)
• Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients (2021 · Frontiers in Oncology · 被引 25)
• Mesenchymal stem cells overexpressing adrenomedullin improve heart function through antifibrotic action in rats experiencing heart failure (2017 · Molecular Medicine Reports · 被引 25)
• Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer (2025 · Clinical and Translational Medicine · 被引 15)